Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HSK-21542 by Sichuan Haisco Pharmaceutical for Post-Operative Pain: Likelihood of Approval
HSK-21542 is under clinical development by Sichuan Haisco Pharmaceutical and currently in Phase III for Post-Operative Pain. According to GlobalData,...
HSK-21542 by Sichuan Haisco Pharmaceutical for Unspecified Toxic Disorders: Likelihood of Approval
HSK-21542 is under clinical development by Sichuan Haisco Pharmaceutical and currently in Phase II for Unspecified Toxic Disorders. According to...
Cipepofol by Sichuan Haisco Pharmaceutical for General Anesthetic Effect: Likelihood of Approval
Cipepofol is under clinical development by Sichuan Haisco Pharmaceutical and currently in Phase III for General Anesthetic Effect. According to...